Osteoporosis and systemic lupus erythematosus: Etiology and treatment strategies

Leigh G. Segal, Nancy E Lane

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The importance of bone loss in patients with systemic lupus erythematosus can not be over emphasized. Risk factors for osteoporosis in these patients include not only those that apply to the general population, but also many that are related to the underlying disease process, or its treatment. Ongoing research should attempt to clarify the prevalence of low bone mass in lupus, as well as the pathogenic mechanisms applying especially to this population. Strategies for the prevention and treatment of bone loss in lupus patients do not differ significantly from those in the general population. Special attention must be given to the prevention of steroid-induced bone loss, as well as to the gonadal effects of cytotoxic agents.

Original languageEnglish (US)
Pages (from-to)281-289
Number of pages9
JournalAnnales de Medecine Interne
Volume147
Issue number4
StatePublished - 1996
Externally publishedYes

Fingerprint

Systemic Lupus Erythematosus
Osteoporosis
Bone and Bones
Population
Cytotoxins
Therapeutics
Steroids
Research

Keywords

  • lupus
  • osteoporosis
  • prevention
  • treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Osteoporosis and systemic lupus erythematosus : Etiology and treatment strategies. / Segal, Leigh G.; Lane, Nancy E.

In: Annales de Medecine Interne, Vol. 147, No. 4, 1996, p. 281-289.

Research output: Contribution to journalArticle

@article{a23b7872a89842bbb07de86a6074aea5,
title = "Osteoporosis and systemic lupus erythematosus: Etiology and treatment strategies",
abstract = "The importance of bone loss in patients with systemic lupus erythematosus can not be over emphasized. Risk factors for osteoporosis in these patients include not only those that apply to the general population, but also many that are related to the underlying disease process, or its treatment. Ongoing research should attempt to clarify the prevalence of low bone mass in lupus, as well as the pathogenic mechanisms applying especially to this population. Strategies for the prevention and treatment of bone loss in lupus patients do not differ significantly from those in the general population. Special attention must be given to the prevention of steroid-induced bone loss, as well as to the gonadal effects of cytotoxic agents.",
keywords = "lupus, osteoporosis, prevention, treatment",
author = "Segal, {Leigh G.} and Lane, {Nancy E}",
year = "1996",
language = "English (US)",
volume = "147",
pages = "281--289",
journal = "Annales de Medecine Interne",
issn = "0003-410X",
publisher = "Masson Publishing",
number = "4",

}

TY - JOUR

T1 - Osteoporosis and systemic lupus erythematosus

T2 - Etiology and treatment strategies

AU - Segal, Leigh G.

AU - Lane, Nancy E

PY - 1996

Y1 - 1996

N2 - The importance of bone loss in patients with systemic lupus erythematosus can not be over emphasized. Risk factors for osteoporosis in these patients include not only those that apply to the general population, but also many that are related to the underlying disease process, or its treatment. Ongoing research should attempt to clarify the prevalence of low bone mass in lupus, as well as the pathogenic mechanisms applying especially to this population. Strategies for the prevention and treatment of bone loss in lupus patients do not differ significantly from those in the general population. Special attention must be given to the prevention of steroid-induced bone loss, as well as to the gonadal effects of cytotoxic agents.

AB - The importance of bone loss in patients with systemic lupus erythematosus can not be over emphasized. Risk factors for osteoporosis in these patients include not only those that apply to the general population, but also many that are related to the underlying disease process, or its treatment. Ongoing research should attempt to clarify the prevalence of low bone mass in lupus, as well as the pathogenic mechanisms applying especially to this population. Strategies for the prevention and treatment of bone loss in lupus patients do not differ significantly from those in the general population. Special attention must be given to the prevention of steroid-induced bone loss, as well as to the gonadal effects of cytotoxic agents.

KW - lupus

KW - osteoporosis

KW - prevention

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=0029791305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029791305&partnerID=8YFLogxK

M3 - Article

C2 - 8952749

AN - SCOPUS:0029791305

VL - 147

SP - 281

EP - 289

JO - Annales de Medecine Interne

JF - Annales de Medecine Interne

SN - 0003-410X

IS - 4

ER -